Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics

FOLD POWR Grades

• FOLD scores best on the Value dimension, with a Value rank ahead of 76.2% of US stocks.
• The strongest trend for FOLD is in Sentiment, which has been heading down over the past 179 days.
• FOLD's current lowest rank is in the Sentiment metric (where it is better than 11.27% of US stocks).

FOLD Stock Summary

• Of note is the ratio of Amicus Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 19.82% of US stocks have a lower such ratio.
• With a price/sales ratio of 9.07, Amicus Therapeutics Inc has a higher such ratio than 83.85% of stocks in our set.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for FOLD comes in at -8.25% -- higher than that of 27.64% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Amicus Therapeutics Inc are PXLW, MNOV, EYEN, CRDF, and TARS.
• FOLD's SEC filings can be seen here. And to visit Amicus Therapeutics Inc's official web site, go to www.amicusrx.com.

FOLD Valuation Summary

• FOLD's price/sales ratio is 10.8; this is 4.85% lower than that of the median Healthcare stock.
• Over the past 174 months, FOLD's price/sales ratio has gone NA NA.
• FOLD's price/earnings ratio has moved down 7.1 over the prior 174 months.

Below are key valuation metrics over time for FOLD.

FOLD Growth Metrics

Its 2 year revenue growth rate is now at 322.02%.
• Its 5 year price growth rate is now at 64.36%.
• Its 2 year price growth rate is now at -16.4%.

FOLD's revenue has moved up $196,919,000 over the prior 34 months.

The table below shows FOLD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	305.514	-202.491	-250.46
2021-09-30	293.931	-181.799	-238.584
2021-06-30	281.823	-200.107	-252.301
2021-03-31	266.763	-197.702	-253.568
2020-12-31	260.886	-233.29	-276.852
2020-09-30	245.608	-241.3	-295.18

FOLD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• FOLD has a Quality Grade of C, ranking ahead of 63.39% of graded US stocks.
• FOLD's asset turnover comes in at 0.333 -- ranking 138th of 680 Pharmaceutical Products stocks.
• RDUS, CLVS, and NSTG are the stocks whose asset turnover ratios are most correlated with FOLD.

The table below shows FOLD's key quality metrics over time.